Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion

Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion

Mantle cell lymphoma is a non-Hodgkin lymphoproliferative neoplasm with several clinical and morphologic variants linked, primarily, through genetic derangement of the cyclin D1 locus. Aberrant phenotypes have been described, though prognostic data in such cohorts are limited due to a paucity of cas...

Full description

Bibliographic Details
Main Authors:	Robert K. McCall, Changlee S. Pang, Mark J. Pettenati
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Case Reports in Hematology
Online Access:	http://dx.doi.org/10.1155/2020/9185432

Similar Items

Mantle cell lymphoma: involvement of nodal and extranodal sites in the head and neck, with multifocal oral lesions
by: Marcelo Marcucci, et al.
Published: (2017-09-01)

Alterations of tumour protein 53 (TP53) pathways in diffuse large B-cell lymphomas
by: Magdi Abdel-Azim, Dalia
Published: (2009)

CD5-negative chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with gastrointestinal mantle cell lymphoma: an unusual case report
by: Chen D, et al.
Published: (2019-04-01)

Limited importance of the dominant-negative effect of <it>TP53 </it>missense mutations
by: Kordek Radzislaw, et al.
Published: (2011-06-01)

The contribution of <it>CHEK2 </it>to the <it>TP53</it>-negative Li-Fraumeni phenotype
by: Ruijs Marielle WG, et al.
Published: (2009-02-01)

Nodal mantle cell lymphoma: A descriptive study from a tertiary care center in South India
by: Arun Roy, et al.
Published: (2013-01-01)

Imunorreatividade da p53 associada à ausência de mutações no gene TP53 em linfomas caninos Immunostaing of p53 associated with absence of mutations in TP53 gene in dogs with lymphoma
by: Sabryna Gouveia Calazans, et al.
Published: (2010-06-01)

Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients
by: Qin Y, et al.
Published: (2020-11-01)

TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas
by: AE Misyurina, et al.
Published: (2019-05-01)

Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
by: Elena N. Voropaeva, et al.
Published: (2019-03-01)

Identification on Mantle Cell Lymphoma Using CD20 and CD5 Coupled Upconversion Fluorescent Nanoprobes
by: Mingkai Zhang, et al.
Published: (2018-01-01)

Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma
by: Caixia Jing, et al.
Published: (2021-06-01)

Concurrent <i>TP53</i> and <i>CDKN2A</i> Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy
by: Diana Malarikova, et al.
Published: (2020-07-01)

Interrelationship between <it>TP53 </it>gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma
by: Demachki Samia, et al.
Published: (2009-07-01)

Development of chronic myelogenous leukemia in a case of chronic lymphocytic leukemia with Tp53 gene deletion
by: A Gupta, et al.
Published: (2015-01-01)

De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
by: Ghaleb Elyamany, et al.
Published: (2015-01-01)

Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
by: Ziduo Li, et al.
Published: (2020-01-01)

The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)

Mantle cell lymphoma
by: V. I. Vorob’ev, et al.
Published: (2020-11-01)

Progress of TP53 Family Gene TP73 and Tumorigenesis
by: XU Jie, et al.
Published: (2021-02-01)

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
by: Jianfeng Zhou, et al.
Published: (2021-06-01)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
by: Dmitriy Sonkin
Published: (2015-10-01)

Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
by: Elisabeth Silden, et al.
Published: (2013-01-01)

CASES OF DIFFUSE LARGE B-CELL LYMPHOMA WITH FUNCTIONAL INTRON MUTATIONS IN THE TP53 GENE
by: E. N. Voropaeva, et al.
Published: (2020-03-01)

Resistência ao tratamento no linfoma de Burkitt: associação com mutações específicas no gene TP53? Treatment resistance in Burkitt's lymphoma: is it associated with specific mutations of the TP53 gene?
by: Eliane P. S. Magluta, et al.
Published: (2008-02-01)

CD80 expression is upregulated by TP53 activation in human cancer epithelial cells
by: Melania Scarpa, et al.
Published: (2021-01-01)

Lenalidomide and the new-generation anti-CD20 antibodies in mantle cell lymphoma
by: Eve, Heather E.
Published: (2012)

TP53 in Biology and Treatment of Osteosarcoma
by: Kamil Jozef Synoradzki, et al.
Published: (2021-08-01)

The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers
by: Magali Olivier, et al.
Published: (2007-02-01)

Cytogenetics of mantle cell lymphoma
by: T N Obukhova, et al.
Published: (2004-07-01)

Smoldering mantle cell lymphoma
by: Haige Ye, et al.
Published: (2017-12-01)

Mantle cell lymphoma pathogenesis
by: deLeeuw, Ronald John
Published: (2009)

Mantle cell lymphoma pathogenesis
by: deLeeuw, Ronald John
Published: (2009)

Mantle cell lymphoma pathogenesis
by: deLeeuw, Ronald John
Published: (2009)

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
by: Alessia Castellino, et al.
Published: (2021-01-01)

BMP7 expression correlates with secondary drug resistance in mantle cell lymphoma.
by: Valérie Camara-Clayette, et al.
Published: (2013-01-01)

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion
by: Yichao Fan, et al.
Published: (2017-08-01)

Deletions of N33, STK11 and TP53 Are Involved in the Development of Lymph Node Metastasis in Larynx and Pharynx Carcinomas
by: Marta Alonso Guervós, et al.
Published: (2007-01-01)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
by: Philippa Li, et al.
Published: (2021-08-01)

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer
by: Leandra Fiori Lopes, et al.
Published: (2014-12-01)